drugset / Trial / NCT01323907
Compassionate Use of Omegaven IV Fat Emulsion
Withdrawn
Sivan Kinberg
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to provide use of Omegaven in children with life threatening Total Parenteral Nutrition (TPN) associated cholestasis when all other medical and surgical treatments/therapies have been either ineffective or not feasible in the treatment of this serious condition. This is a compassionate use protocol.
Timeline
- Start
- 2011-01
- Primary completion
- 2019-02-13
- Completion
- 2019-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omegaven | Other / unclassified | 1 g/kg | Intravenous |